Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Methylpyrimidine >  2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester

2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester

Basic information Safety Supplier Related

2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester Basic information

Product Name:
2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester
Synonyms:
  • (S)-methyl 2-(morpholin-3-yl)acetate HCL
  • methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylatemethyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate
  • 2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester
  • (3-BROMOPHENYL)(3-PYRIDINYL)METHANONE
  • Methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate
  • 5-Pyrimidinecarboxylic acid, 2,4-dichloro-6-methyl-, methyl ester
  • 2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester ISO 9001:2015 REACH
  • Methyl 2,4-dichloro-6-methyl-5-pyrimidinecarboxylate
CAS:
36745-93-4
MF:
C7H6Cl2N2O2
MW:
221.04
Mol File:
36745-93-4.mol
More
Less

2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester Chemical Properties

Boiling point:
292℃
Density 
1.435
Flash point:
131℃
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-3.83±0.39(Predicted)
Appearance
White to yellow Solid
More
Less

2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester Usage And Synthesis

Uses

2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic Acid Methyl Ester is used in preparation of 4,6,7-Trisubstituted 1,2-dihydropyrrol[3,4-c]pyridin/pyrimidin-3 -one derivatives useful as Btk kinase inhibitors.

Synthesis

869891-41-8

36745-93-4

General procedure for the synthesis of methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate from methyl 2,4-dihydroxy-6-methylpyridine-5-carboxylate: 6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid methyl ester (1 g, 5.43 mmol) was suspended in POCl3 (10 mL) and N,N-dimethylaniline (10 drops ). The reaction mixture was heated at 105 °C for 6 h until a clarified solution was formed. Upon completion of the reaction, the mixture was cooled to room temperature, concentrated under reduced pressure and subsequently poured into ice water and extracted with ethyl acetate (EtOAc). The organic phases were combined, washed sequentially with water and saturated brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate (940 mg, 78% yield) as a yellow-green solid. Mass spectrometry analysis: [M + H]+ C7H6Cl2N2O2 calculated value was 222, measured values were 221 and 223.

References

[1] Patent: US2011/152273, 2011, A1. Location in patent: Page/Page column 28
[2] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 24, p. 5947 - 5950
[3] Patent: WO2015/131080, 2015, A1. Location in patent: Paragraph 00270; 00274
[4] Patent: US2014/148454, 2014, A1. Location in patent: Paragraph 0676
[5] Patent: WO2014/82739, 2014, A1. Location in patent: Page/Page column 59

2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl esterSupplier

JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com
Shangchem Co., Ltd.
Tel
+86-21-68182121
Nanjing Habo Medical Technology Co., Ltd.
Tel
025-85760892 13376080562
Email
sales@habotech.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
skychemical Co.Ltd
Tel
021-20958197 20965099
Email
sales@skychemical.com